申请人:HELSINN HEALTHCARE SA
公开号:US20140121210A1
公开(公告)日:2014-05-01
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I):